𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

✍ Scribed by A. Novotna; J. Mares; S. Ratcliffe; I. Novakova; M. Vachova; O. Zapletalova; C. Gasperini; C. Pozzilli; L. Cefaro; G. Comi; P. Rossi; Z. Ambler; Z. Stelmasiak; A. Erdmann; X. Montalban; A. Klimek; P. Davies; the Sativex Spasticity Study Group


Book ID
111066638
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
244 KB
Volume
18
Category
Article
ISSN
1351-5101

No coin nor oath required. For personal study only.